Clopidogrel for reduction of atherosclerotic events.
D000284:Administration, Oral; D001161:Arteriosclerosis / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D004347:Drug Interactions; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine